During the past decade, Clinique Chenieux conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Chenieux" #1 sponsor was "UNICANCER" with 5 trials, followed by "Federation Francophone de Cancerologie Digestive" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Averitas Pharma, Inc." with 1 trials sponsored and "Centre Hospitalier Universitaire Dijon" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Chenieux" #1 collaborator was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator, "National Cancer Institute, France" with 2 trials as a collaborator, "UNICANCER" with 2 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "Cancer International Research Group (CIRG)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Chenieux" are "Urinary Bladder Neoplasms" (3 trials), "Breast Cancer" (2 trials), "Acute Kidney Injury (AKI)" (1 trials), "Adenocarcinoma of the Gastroesophageal Junction" (1 trials) and "Adenocarcinoma of the Oesogastric Junction (Siewert Type I or II)" (1 trials). Many other conditions were trialed in "Clinique Chenieux" in a lesser frequency.

Most popular intervention types in "Clinique Chenieux" are "Drug" (19 trials), "Biological" (6 trials), "Procedure" (4 trials), "Radiation" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Cetrelimab" (3 trials), "TAR-200" (3 trials), "adjuvant therapy" (3 trials), "Docetaxel" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Chenieux" are 21 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique Chenieux". undefined are not yet recruiting, 10 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Clinique Chenieux, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Chenieux, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".